Chaim Indig Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 9 hours ago
Chaim Indig has an estimated net worth of at least $42.2 million*, as of Feb. 12, 2025. They own 1.3 million shares of PHR stock. They have sold 196,803 shares of PHR stock since 2021, for an estimated $6.5 million.
Chaim Indig $PHR SEC Form 4 Insider Trading
Chaim Indig has filed a total of 21 insider trades in $PHR since 2021. Their most recent trade was a sale of 7,923 shares, made on Jan 27, 2025. Their largest trade was a sale of 63,931 shares, made on Jan 17, 2024. We estimate that they now own 1.3 million shares of $PHR, worth an estimated $35.6 million.
Insider Trading at $PHR
There have been a total of 263 insider trades reported at $PHR since 2021, with 0 shares purchased and 1.1 million shares sold. The most active insider traders in $PHR stock have been David Linetsky, Evan Roberts, and Allison C Hoffman. The most recent trade was a sale of 300 shares reported by David Linetsky (SVP, Life Sciences), made on Feb 07, 2025.
History of Insider Stock Trades by Chaim Indig
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 7,923 | Jan 27, 2025 | Jan. 29, 2025, 5:45 p.m. |
![]() |
Sale | 18,325 | Jan 27, 2025 | Jan. 29, 2025, 5:45 p.m. |
![]() |
Sale | 21,692 | Jan 21, 2025 | Jan. 22, 2025, 5:56 p.m. |
![]() |
Sale | 2,990 | Jan 15, 2025 | Jan. 17, 2025, 7:08 p.m. |
![]() |
Sale | 5,375 | Jan 06, 2025 | Jan. 8, 2025, 6:23 p.m. |
![]() |
Sale | 3,089 | Oct 15, 2024 | Oct. 17, 2024, 4:33 p.m. |
![]() |
Sale | 5,295 | Sep 10, 2024 | Sept. 12, 2024, 6 p.m. |
![]() |
Sale | 7 | Jul 29, 2024 | July 30, 2024, 5:05 p.m. |
![]() |
Sale | 2,644 | Jul 16, 2024 | July 17, 2024, 5:30 p.m. |
![]() |
Sale | 3,392 | Apr 15, 2024 | April 17, 2024, 4:07 p.m. |
![]() |
Sale | 120 | Apr 08, 2024 | April 10, 2024, 5:19 p.m. |
![]() |
Sale | 11,923 | Apr 08, 2024 | April 10, 2024, 5:19 p.m. |
![]() |
Sale | 3,586 | Jan 16, 2024 | Jan. 18, 2024, 5:51 p.m. |
![]() |
Sale | 63,931 | Jan 17, 2024 | Jan. 18, 2024, 5:51 p.m. |
![]() |
Sale | 3,295 | Oct 16, 2023 | Oct. 17, 2023, 6:08 p.m. |
![]() |
Sale | 6,293 | Sep 13, 2023 | Sept. 14, 2023, 5:06 p.m. |
![]() |
Sale | 262 | Sep 13, 2023 | Sept. 14, 2023, 5:06 p.m. |
![]() |
Sale | 28,120 | Aug 05, 2021 | Aug. 8, 2021, 8 p.m. |
![]() |
Sale | 1,660 | Aug 06, 2021 | Aug. 8, 2021, 8 p.m. |
![]() |
Sale | 6,779 | Jul 29, 2021 | Aug. 1, 2021, 8 p.m. |
![]() |
Sale | 102 | Jul 30, 2021 | Aug. 1, 2021, 8 p.m. |
$PHR Executives and Stock Owners with Insider Trades
-
David Linetsky, SVP, Life Sciences
-
Evan Roberts, Chief Operating Officer
-
Allison C Hoffman, General Counsel & Secretary
-
Amy Beth Vanduyn, SVP, Human Resources
-
Chaim Indig, Chief Executive Officer
-
Balaji Gandhi, Chief Financial Officer
-
Michael J. Davidoff, SVP, Payer Business
-
Janet Gunzburg, Principal Accounting Officer
-
Yvonne Hui, Principal Accounting Officer
-
Randy Rasmussen, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.